The FDA gave its nod to Milford, Penn.-based Serenity Pharmaceuticals LLC's Noctiva (desmopressin acetate) nasal spray for nocturnal polyuria (overproduction of urine during the night) in adults who awaken at least two times per night to urinate. It's the first FDA-approved treatment for that condition.